This work is licensed under the Creative Commons Attribution 4.0 International License.
Coureuil M, Join-Lambert O, Lécuyer H, Bourdoulous S, Marullo S, Nassif X. Pathogenesis of meningococcemia. Cold Spring Harb Perspect Med. 2013; 3(6):a012393CoureuilMJoin-LambertOLécuyerHBourdoulousSMarulloSNassifXPathogenesis of meningococcemiaCold Spring Harb Perspect Med201336a01239310.1101/cshperspect.a012393366235023732856Search in Google Scholar
Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence 2014; 5(1): 36-44WiersingaWJLeopoldSJCranendonkDRvander Poll THost innate immune responses to sepsisVirulence20145136-4410.4161/viru.25436391638123774844Search in Google Scholar
Uchino S, Kellum JA, Bellomo R, et al. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 2005; 294: 813–818UchinoSKellumJABellomoRet alBeginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: A multinational, multicenter studyJAMA200529481381810.1001/jama.294.7.81316106006Search in Google Scholar
Ankawi G, Neri M, Zhang J, Breglia A, Ricci Z, Ronco C. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls. Crit Care 2018; 22: 262AnkawiGNeriMZhangJBregliaARicciZRoncoCExtracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfallsCrit Care20182226210.1186/s13054-018-2181-z620285530360755Search in Google Scholar
Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018; 44(6):925-928LevyMMEvansLERhodesAThe Surviving Sepsis Campaign Bundle: 2018 updateIntensive Care Med2018446925-92810.1097/CCM.000000000000311929767636Search in Google Scholar
Hattori N, Oda S. Cytokine-adsorbing hemofilter: old but new modality for septic acute kidney injury. Renal Replacement Therapy 2016; 2(1):41HattoriNOdaSCytokine-adsorbing hemofilter: old but new modality for septic acute kidney injuryRenal Replacement Therapy2016214110.1186/s41100-016-0051-1Search in Google Scholar
Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018; 6:12MalardBLambertCKellumJAIn vitro comparison of the adsorption of inflammatory mediators by blood purification devicesIntensive Care Med Exp201861210.1186/s40635-018-0177-2593560129728790Search in Google Scholar
Shum HP, Chan KC, Kwan MC, Yan WW. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram negative bacterial infection. Hong Kong Med J. 2013; 19 :491–7ShumHPChanKCKwanMCYanWWApplication of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram negative bacterial infectionHong Kong Med J201319491710.12809/hkmj13391023650198Search in Google Scholar
Turani F, Candidi F, Barchetta R, et al. Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: A clinical experience. Crit Care 2013; 17:S22–3TuraniFCandidiFBarchettaRet alContinuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: A clinical experienceCrit Care201317S22310.1186/cc12001Search in Google Scholar
Gruda MC, Ruggeberg KG, O’Sullivan P, et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS One 2018; 13(1): e0191676GrudaMCRuggebergKGO’SullivanPet alBroad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beadsPLoS One2018131e019167610.1371/journal.pone.0191676578493129370247Search in Google Scholar
Rampino T, Gregorini M, Perotti L, et al. Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia. Blood Purif 2021; 50:566-571RampinoTGregoriniMPerottiLet alHemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 PneumoniaBlood Purif20215056657110.1159/000511725770593933181508Search in Google Scholar
Napp LC, Lebreton G, De Somer F, Supady A, Pappalardo F. Opportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMO. Artif Organs. 2021; 45(10):1240-1249.NappLCLebretonGDeSomer FSupadyAPappalardoFOpportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMOArtif Organs202145101240124910.1111/aor.1402534152637Search in Google Scholar